Insys Therapeutics Reports Fourth Quarter and Year End 2015 Results
Feb 23, 2016 11:50 am UTC| Business
PHOENIX, Feb. 23, 2016 -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") today announced financial results for the three- and twelve-month periods ended December 31, 2015. Highlights of and...
BioCryst Reports Fourth Quarter & Full Year 2015 Financial Results
Feb 23, 2016 11:50 am UTC| Business
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2016 -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the fourth quarter and full year ended December 31, 2015. “In 2015, we gained clarity...
Sucampo Announces Fourth Quarter and Full Year 2015 Earnings Call
Feb 23, 2016 11:45 am UTC| Business
ROCKVILLE, Md., Feb. 23, 2016 -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter and full year 2015 financial results...
World Laboratory Information Systems Market Report 2015-2020
Feb 23, 2016 11:43 am UTC| Business
Dublin, Feb. 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/dlpxvp/the_world_market) has announced the addition of the "The World Market for Laboratory Information Systems" ...
Global Vascular Closure Devices (VCD) Market 2016-2022
Feb 23, 2016 11:38 am UTC| Business
Dublin, Feb. 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/djbmxd/vascular_closure) has announced the addition of the "Vascular Closure Devices (VCD) Global Market - Forecast...
Feb 23, 2016 11:37 am UTC| Business
Palo Alto, CA, Feb. 23, 2016 -- PARC, a Xerox company, today announced it has secured funding from the US Department of Energy’s Advanced Research Projects Agency-Energy (ARPA-E) under the Traveler Response Architecture...
CytoDyn Initiates Phase 3 Monotherapy Trial for HIV Patients
Feb 23, 2016 11:30 am UTC| Business
VANCOUVER, Wash., Feb. 23, 2016 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, today announced...